PA
EVO icon

Parallel Advisors’s Evotec EVO Stock Holding History

Parallel Advisors’s Portfolio EVO Stock Details EVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-98
Closed -$408 – 3559
2024
Q4 		$408 Sell
98
-76
-44% -$319 ﹤0.01% 3260
2024
Q3 		$635 Sell
174
-1,366
-89% -$5.42K ﹤0.01% 3140
2024
Q2 		$7.39K Buy
1,540
+1,470
+2,100% +$8.24K ﹤0.01% 2418
2024
Q1 		$548 Hold
70
– – ﹤0.01% 3042
2023
Q4 		$821 Hold
70
– – ﹤0.01% 2974
2023
Q3 		$691 Hold
70
– – ﹤0.01% 3044
2023
Q2 		$791 Hold
70
– – ﹤0.01% 2988
2023
Q1 		$732 Hold
70
– – ﹤0.01% 3022
2022
Q4 		$566 Sell
70
-146
-68% -$1.28K ﹤0.01% 3018
2022
Q3 		$2K Buy
216
+122
+130% +$1.46K ﹤0.01% 2639
2022
Q2 		$1K Sell
94
-150
-61% -$1.96K ﹤0.01% 2750
2022
Q1 		$4K Buy
+244
New +$4.17K ﹤0.01% 2358

Other funds holding EVO

MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return
FC
Fore Capital New York $162M AUM 14.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Parallel Advisors's EVO Position: Q1 2025 in Review

Parallel Advisors sold out of Evotec (EVO) in Q1 2025, closing a stake of 98 shares — an estimated $408 sold.

Parallel Advisors first reported a position in EVO in Q1 2022 and held it in 12 quarters. The position peaked at $7.39K in Q2 2024. 25 funds tracked by Wall St. Rank hold EVO as of Q1 2025.

  • Parallel Advisors reported no remaining Evotec position as of Q1 2025 after selling out during the quarter.
  • Parallel Advisors sold 98 Evotec shares in Q1 2025, an estimated $408.
  • Parallel Advisors first reported a position in Evotec in Q1 2022 and held it in 12 quarters.
  • Parallel Advisors's Evotec position peaked at $7.39K in Q2 2024.
  • 25 funds tracked by Wall St. Rank held Evotec as of Q1 2025.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.